TerrAscend (TSNDF) Receivables (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Receivables of $17.2 million for Q1 2026, down 16.14% year-over-year from $20.5 million in Q1 2025, and down 2.19% quarter-over-quarter from $17.6 million in Q4 2025.
TerrAscend (TSNDF) Receivables (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Receivables for 6 consecutive years, with $17.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables fell 16.14% year-over-year to $17.2 million; the TTM figure through Mar 2026 stood at $17.2 million (down 16.14% YoY), while the FY2025 annual figure was $17.6 million, down 15.52% from the prior year.
- Receivables fell to $17.2 million in Q1 2026 per TSNDF's latest filing, from $17.6 million in the prior quarter.
- Across five years, Receivables topped out at $32.7 million in Q4 2022 and bottomed at $16.1 million in Q3 2023.
- Historically, Receivables has averaged $20.0 million across 5 years, with a median of $19.6 million in 2023.
- Annual changes were most pronounced in 2022 — Receivables jumped 161.69% — and 2023, when it tumbled 38.26%.
- TerrAscend's Receivables stood at $32.7 million in 2022, then tumbled by 38.26% to $20.2 million in 2023, then advanced by 2.9% to $20.8 million in 2024, then retreated by 15.52% to $17.6 million in 2025, then decreased by 2.19% to $17.2 million in 2026.
- Business Quant data shows TSNDF's Receivables at $17.2 million in Q1 2026, $17.6 million in Q4 2025, and $17.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.08 Bn |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | 17.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.87 Mn |
| Mar 31, 2026 | 17.18 Mn |
| Dec 31, 2025 | 17.56 Mn |
| Sep 30, 2025 | 17.65 Mn |
| Jun 30, 2025 | 20.32 Mn |
| Mar 31, 2025 | 20.48 Mn |
| Dec 31, 2024 | 20.79 Mn |
| Sep 30, 2024 | 17.75 Mn |
| Jun 30, 2024 | 17.34 Mn |
| Mar 31, 2024 | 17.90 Mn |
| Dec 31, 2023 | 20.20 Mn |
| Sep 30, 2023 | 16.10 Mn |
| Jun 30, 2023 | 20.21 Mn |
| Mar 31, 2023 | 19.64 Mn |
| Dec 31, 2022 | 32.72 Mn |
| Sep 30, 2022 | 18.40 Mn |
| Jun 30, 2022 | 22.78 Mn |
| Mar 31, 2022 | 23.70 Mn |
| Dec 31, 2021 | 12.50 Mn |